Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Diabetes. 2022 Mar 1;71(3):530–537. doi: 10.2337/db21-0517

Figure 2.

Figure 2

Comparison of clinical features in patients with m.3243A>G diabetes diagnosed by unselected testing using tNGS and by clinically suspected testing using a TaqMan genotyping assay undertaken as requested by the referring clinician. Filled bars are patients with diabetes and the m.3243A>G mutation identified by targeted tNGS in a suspected MODY cohort and unfilled bars are patients with m.3243A>G identified when clinically suspected of having MIDD.